Literature DB >> 14638498

Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

Hesna Yigit1, Anne Marie Queenan, J Kamile Rasheed, James W Biddle, Antonio Domenech-Sanchez, Sebastian Alberti, Karen Bush, Fred C Tenover.   

Abstract

We investigated a Klebsiella oxytoca isolate demonstrating resistance to imipenem, meropenem, extended-spectrum cephalosporins, and aztreonam. The MICs of both imipenem and meropenem were 32 microg/ml. The beta-lactamase activity against imipenem and meropenem was inhibited in the presence of clavulanic acid. Isoelectric focusing studies demonstrated five beta-lactamases with pIs of 8.2 (SHV-46), 6.7 (KPC-2), 6.5 (unknown), 6.4 (probable OXY-2), and 5.4 (TEM-1). The presence of the bla(SHV) and bla(TEM) genes was confirmed by specific PCR assays and DNA sequence analysis. Transformation and conjugation studies with Escherichia coli showed that the beta-lactamase with a pI of 6.7, Klebsiella pneumoniae carbapenemase-2 (KPC-2), was encoded on an approximately 70-kb conjugative plasmid that also carried SHV-46, TEM-1, and the beta-lactamase with a pI of 6.5. The bla(KPC-2) determinant was cloned in E. coli and conferred resistance to imipenem, meropenem, extended-spectrum cephalosporins, and aztreonam. The amino acid sequence of KPC-2 showed a single amino acid difference, S174G, when compared with KPC-1, another carbapenem-hydrolyzing beta-lactamase from K. pneumoniae 1534. Hydrolysis studies showed that purified KPC-2 hydrolyzed not only carbapenems but also penicillins, cephalosporins, and aztreonam. KPC-2 had the highest affinity for meropenem. The kinetic studies revealed that KPC-2 was inhibited by clavulanic acid and tazobactam. An examination of the outer membrane proteins of the parent K. oxytoca strain demonstrated that it expressed detectable levels of OmpK36 (the homolog of OmpC) and a higher-molecular-weight OmpK35 (the homolog of OmpF). Thus, carbapenem resistance in K. oxytoca 3127 is due to production of the Bush group 2f, class A, carbapenem-hydrolyzing beta-lactamase KPC-2. This beta-lactamase is likely located on a transposon that is part of a conjugative plasmid and thus has a very high potential for dissemination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638498      PMCID: PMC296202          DOI: 10.1128/AAC.47.12.3881-3889.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Properties of plasmids responsible for production of extended-spectrum beta-lactamases.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 2.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  The graphical determination of K m and K i .

Authors:  M Dixon
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

4.  Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy.

Authors:  M Matthew; A M Harris
Journal:  J Gen Microbiol       Date:  1976-05

5.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Authors:  E H Lee; M H Nicolas; M D Kitzis; G Pialoux; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

7.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.

Authors:  R B Sykes; D P Bonner; K Bush; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

8.  Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.

Authors:  A Raimondi; A Traverso; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins.

Authors:  D A Portnoy; H Wolf-Watz; I Bolin; A B Beeder; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.

Authors:  Vivi Miriagou; Leonidas S Tzouvelekis; Shannon Rossiter; Eva Tzelepi; Frederick J Angulo; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

View more
  90 in total

1.  Chromosome-encoded extended-spectrum class A β-lactamase MIN-1 from Minibacterium massiliensis.

Authors:  Béatrice Bercot; Patrice Nordmann; Michel Drancourt; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2012-04-23       Impact factor: 5.191

2.  A pilot survey of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae mediated by K pneumoniae serine carbapenemases in a regional referral hospital in British Columbia.

Authors:  Aubrey Shannon; Ken Wagner; Naowarat Cheeptham; Gwen Stephens
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

3.  Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Authors:  Neil Woodford; Philip M Tierno; Katherine Young; Luke Tysall; Marie-France I Palepou; Elaina Ward; Ronald E Painter; Deborah F Suber; Daniel Shungu; Lynn L Silver; Kenneth Inglima; John Kornblum; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Jimena Alba; Yoshikazu Ishii; Kenneth Thomson; Ellen Smith Moland; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

5.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France.

Authors:  Thierry Naas; Patrice Nordmann; Gérard Vedel; Claire Poyart
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.

Authors:  Ashfaque Hossain; M J Ferraro; R M Pino; R B Dew; E S Moland; T J Lockhart; K S Thomson; R V Goering; N D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Carlos Jose Suarez; Jaime A Lopez; Marta Vallejo; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 8.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.